[144] ZIPRECRUITER, INC. SEC Filing
Rhea-AI Filing Summary
ZIPRECRUITER, INC. (ZIP) filing of Form 144 notifies the market of a proposed sale of 18,793 common shares through Goldman Sachs & Co. LLC with an aggregate market value of $100,730.48, to be sold on 09/18/2025 on the NYSE. The notice shows these shares were largely acquired as restricted stock units (RSUs) on 09/15/2025 as compensation, with specific lots of 6,226, 9,652, and 2,915 shares listed. The filer previously sold an identical amount (18,793 shares) on 06/18/2025 for gross proceeds of $95,699.59. The form includes the required certification that the seller is not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale disclosure; size is small relative to outstanding shares and appears to be compensation-related.
The Form 144 notifies the market of a proposed sale of 18,793 shares valued at $100,730.48 to be executed through Goldman Sachs on the NYSE. The filing documents that the underlying shares were received as RSUs on 09/15/2025, indicating the sale is linked to compensation vesting rather than an unrelated liquidity event. Compared with the reported 74,088,830 shares outstanding, the sale represents a de minimis portion of equity (~0.025%). From a market-impact perspective this is unlikely to affect valuation materially but is important for transparency and insider activity monitoring.
TL;DR: Disclosure aligns with Rule 144 requirements; shows compliance but signals insider monetization of compensation awards.
The filing contains the standard representation that the seller lacks undisclosed material adverse information and documents prior sales in the past three months. The shares to be sold were acquired as compensation (RSUs) on 09/15/2025 and are being registered for sale under Section 144. While the amounts are modest relative to total shares outstanding, filings like this are useful to assess executive/insider behavior and timing relative to corporate disclosures.